CAS: 2630904-45-7
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
(2R)-2-(4-(4-(Aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1H-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile REF: IN-DA023ZD2CAS: 2630904-45-7 | 98% | A consultar | Mar 07 Ene 25 | |
MRTX-1719 REF: TM-T40254CAS: 2630904-45-7 | 98.27% - 99.18% | 369,00 €~3.347,00 € | Lun 13 Ene 25 |
(2R)-2-(4-(4-(Aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1H-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile
CAS:2630904-45-7
Fórmula:
C23H18ClFN6O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
464.8794
Ref: IN-DA023ZD2
10mg | 183,00 € | ||
25mg | 483,00 € | ||
50mg | 579,00 € | ||
100mg | A consultar | ||
250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
MRTX-1719
CAS:2630904-45-7
MRTX-1719 is a potent and selective inhibitor of the PRMT5/MTA complex with an IC50 value …
Fórmula:
C23H18ClFN6O2
Pureza:
98.27% - 99.18%
Forma y color:
Solid
Peso molecular:
464.88
Ref: TM-T40254
1mg | 369,00 € | ||
5mg | 720,00 € | ||
10mg | 979,00 € | ||
25mg | 1.636,00 € | ||
50mg | 2.292,00 € | ||
100mg | 3.347,00 € | ||
1mL*10mM (DMSO) | 739,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025